
Global Hydroxyzine Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031
Description
Summary
According to APO Research, The global Hydroxyzine market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Hydroxyzine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Hydroxyzine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Hydroxyzine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Hydroxyzine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Hydroxyzine include GSK, Impax Laboratories, N&R Industries, Novartis, Pfizer, Piramal Group (Piramal Healthcare UK Limited), Shanghai Ruizheng Chemical Technology, Teva Pharmaceuticals and Alliance Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Hydroxyzine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Hydroxyzine, also provides the sales of main regions and countries. Of the upcoming market potential for Hydroxyzine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Hydroxyzine sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Hydroxyzine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Hydroxyzine sales, projected growth trends, production technology, application and end-user industry.
Hydroxyzine Segment by Company
GSK
Impax Laboratories
N&R Industries
Novartis
Pfizer
Piramal Group (Piramal Healthcare UK Limited)
Shanghai Ruizheng Chemical Technology
Teva Pharmaceuticals
Alliance Pharma
Hydroxyzine Segment by Type
Tablets
Capsules
Other
Hydroxyzine Segment by Application
Hospitals
Retail Pharmacy
Hydroxyzine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hydroxyzine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hydroxyzine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hydroxyzine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Hydroxyzine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hydroxyzine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hydroxyzine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Hydroxyzine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
According to APO Research, The global Hydroxyzine market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Hydroxyzine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Hydroxyzine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Hydroxyzine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Hydroxyzine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Hydroxyzine include GSK, Impax Laboratories, N&R Industries, Novartis, Pfizer, Piramal Group (Piramal Healthcare UK Limited), Shanghai Ruizheng Chemical Technology, Teva Pharmaceuticals and Alliance Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Hydroxyzine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Hydroxyzine, also provides the sales of main regions and countries. Of the upcoming market potential for Hydroxyzine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Hydroxyzine sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Hydroxyzine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Hydroxyzine sales, projected growth trends, production technology, application and end-user industry.
Hydroxyzine Segment by Company
GSK
Impax Laboratories
N&R Industries
Novartis
Pfizer
Piramal Group (Piramal Healthcare UK Limited)
Shanghai Ruizheng Chemical Technology
Teva Pharmaceuticals
Alliance Pharma
Hydroxyzine Segment by Type
Tablets
Capsules
Other
Hydroxyzine Segment by Application
Hospitals
Retail Pharmacy
Hydroxyzine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hydroxyzine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hydroxyzine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hydroxyzine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Hydroxyzine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hydroxyzine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hydroxyzine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Hydroxyzine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
189 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Hydroxyzine Market Size, 2020 VS 2024 VS 2031
- 1.3 Global Hydroxyzine Market Size Estimates and Forecasts (2020-2031)
- 1.4 Global Hydroxyzine Sales Estimates and Forecasts (2020-2031)
- 1.5 Global Hydroxyzine Market Average Price (2020-2031)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 2 Global Hydroxyzine Market Dynamics
- 2.1 Hydroxyzine Industry Trends
- 2.2 Hydroxyzine Industry Drivers
- 2.3 Hydroxyzine Industry Opportunities and Challenges
- 2.4 Hydroxyzine Industry Restraints
- 3 Hydroxyzine Market by Manufacturers
- 3.1 Global Hydroxyzine Revenue by Manufacturers (2020-2025)
- 3.2 Global Hydroxyzine Sales by Manufacturers (2020-2025)
- 3.3 Global Hydroxyzine Average Sales Price by Manufacturers (2020-2025)
- 3.4 Global Hydroxyzine Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
- 3.5 Global Hydroxyzine Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Hydroxyzine Manufacturers, Product Type & Application
- 3.7 Global Hydroxyzine Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Hydroxyzine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Hydroxyzine Players Market Share by Revenue in 2024
- 3.8.3 2024 Hydroxyzine Tier 1, Tier 2, and Tier 3
- 4 Hydroxyzine Market by Type
- 4.1 Hydroxyzine Type Introduction
- 4.1.1 Tablets
- 4.1.2 Capsules
- 4.1.3 Other
- 4.2 Global Hydroxyzine Sales by Type
- 4.2.1 Global Hydroxyzine Sales by Type (2020 VS 2024 VS 2031)
- 4.2.2 Global Hydroxyzine Sales by Type (2020-2031)
- 4.2.3 Global Hydroxyzine Sales Market Share by Type (2020-2031)
- 4.3 Global Hydroxyzine Revenue by Type
- 4.3.1 Global Hydroxyzine Revenue by Type (2020 VS 2024 VS 2031)
- 4.3.2 Global Hydroxyzine Revenue by Type (2020-2031)
- 4.3.3 Global Hydroxyzine Revenue Market Share by Type (2020-2031)
- 5 Hydroxyzine Market by Application
- 5.1 Hydroxyzine Application Introduction
- 5.1.1 Hospitals
- 5.1.2 Retail Pharmacy
- 5.2 Global Hydroxyzine Sales by Application
- 5.2.1 Global Hydroxyzine Sales by Application (2020 VS 2024 VS 2031)
- 5.2.2 Global Hydroxyzine Sales by Application (2020-2031)
- 5.2.3 Global Hydroxyzine Sales Market Share by Application (2020-2031)
- 5.3 Global Hydroxyzine Revenue by Application
- 5.3.1 Global Hydroxyzine Revenue by Application (2020 VS 2024 VS 2031)
- 5.3.2 Global Hydroxyzine Revenue by Application (2020-2031)
- 5.3.3 Global Hydroxyzine Revenue Market Share by Application (2020-2031)
- 6 Global Hydroxyzine Sales by Region
- 6.1 Global Hydroxyzine Sales by Region: 2020 VS 2024 VS 2031
- 6.2 Global Hydroxyzine Sales by Region (2020-2031)
- 6.2.1 Global Hydroxyzine Sales by Region (2020-2025)
- 6.2.2 Global Hydroxyzine Sales Forecasted by Region (2025-2030)
- 6.3 North America
- 6.3.1 North America Hydroxyzine Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.3.2 North America Hydroxyzine Sales by Country (2020-2031)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Hydroxyzine Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.4.2 Europe Hydroxyzine Sales by Country (2020-2031)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Hydroxyzine Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.5.2 Asia Pacific Hydroxyzine Sales by Country (2020-2031)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Hydroxyzine Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.6.2 South America, Middle East and Africa Hydroxyzine Sales by Country (2020-2031)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
- 7 Global Hydroxyzine Revenue by Region
- 7.1 Global Hydroxyzine Revenue by Region
- 7.1.1 Global Hydroxyzine Revenue by Region: 2020 VS 2024 VS 2031
- 7.1.2 Global Hydroxyzine Revenue by Region (2020-2025)
- 7.1.3 Global Hydroxyzine Revenue by Region (2026-2031)
- 7.1.4 Global Hydroxyzine Revenue Market Share by Region (2020-2031)
- 7.2 North America
- 7.2.1 North America Hydroxyzine Revenue (2020-2031)
- 7.2.2 North America Hydroxyzine Revenue Share by Country: 2020 VS 2024 VS 2031
- 7.3 Europe
- 7.3.1 Europe Hydroxyzine Revenue (2020-2031)
- 7.3.2 Europe Hydroxyzine Revenue Share by Country: 2020 VS 2024 VS 2031
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Hydroxyzine Revenue (2020-2031)
- 7.4.2 Asia-Pacific Hydroxyzine Revenue Share by Country: 2020 VS 2024 VS 2031
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Hydroxyzine Revenue (2020-2031)
- 7.5.2 South America, Middle East and Africa Hydroxyzine Revenue Share by Country: 2020 VS 2024 VS 2031
- 8 Company Profiles
- 8.1 GSK
- 8.1.1 GSK Comapny Information
- 8.1.2 GSK Business Overview
- 8.1.3 GSK Hydroxyzine Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.1.4 GSK Hydroxyzine Product Portfolio
- 8.1.5 GSK Recent Developments
- 8.2 Impax Laboratories
- 8.2.1 Impax Laboratories Comapny Information
- 8.2.2 Impax Laboratories Business Overview
- 8.2.3 Impax Laboratories Hydroxyzine Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.2.4 Impax Laboratories Hydroxyzine Product Portfolio
- 8.2.5 Impax Laboratories Recent Developments
- 8.3 N&R Industries
- 8.3.1 N&R Industries Comapny Information
- 8.3.2 N&R Industries Business Overview
- 8.3.3 N&R Industries Hydroxyzine Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.3.4 N&R Industries Hydroxyzine Product Portfolio
- 8.3.5 N&R Industries Recent Developments
- 8.4 Novartis
- 8.4.1 Novartis Comapny Information
- 8.4.2 Novartis Business Overview
- 8.4.3 Novartis Hydroxyzine Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.4.4 Novartis Hydroxyzine Product Portfolio
- 8.4.5 Novartis Recent Developments
- 8.5 Pfizer
- 8.5.1 Pfizer Comapny Information
- 8.5.2 Pfizer Business Overview
- 8.5.3 Pfizer Hydroxyzine Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.5.4 Pfizer Hydroxyzine Product Portfolio
- 8.5.5 Pfizer Recent Developments
- 8.6 Piramal Group (Piramal Healthcare UK Limited)
- 8.6.1 Piramal Group (Piramal Healthcare UK Limited) Comapny Information
- 8.6.2 Piramal Group (Piramal Healthcare UK Limited) Business Overview
- 8.6.3 Piramal Group (Piramal Healthcare UK Limited) Hydroxyzine Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.6.4 Piramal Group (Piramal Healthcare UK Limited) Hydroxyzine Product Portfolio
- 8.6.5 Piramal Group (Piramal Healthcare UK Limited) Recent Developments
- 8.7 Shanghai Ruizheng Chemical Technology
- 8.7.1 Shanghai Ruizheng Chemical Technology Comapny Information
- 8.7.2 Shanghai Ruizheng Chemical Technology Business Overview
- 8.7.3 Shanghai Ruizheng Chemical Technology Hydroxyzine Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.7.4 Shanghai Ruizheng Chemical Technology Hydroxyzine Product Portfolio
- 8.7.5 Shanghai Ruizheng Chemical Technology Recent Developments
- 8.8 Teva Pharmaceuticals
- 8.8.1 Teva Pharmaceuticals Comapny Information
- 8.8.2 Teva Pharmaceuticals Business Overview
- 8.8.3 Teva Pharmaceuticals Hydroxyzine Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.8.4 Teva Pharmaceuticals Hydroxyzine Product Portfolio
- 8.8.5 Teva Pharmaceuticals Recent Developments
- 8.9 Alliance Pharma
- 8.9.1 Alliance Pharma Comapny Information
- 8.9.2 Alliance Pharma Business Overview
- 8.9.3 Alliance Pharma Hydroxyzine Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.9.4 Alliance Pharma Hydroxyzine Product Portfolio
- 8.9.5 Alliance Pharma Recent Developments
- 9 Value Chain and Sales Channels Analysis
- 9.1 Hydroxyzine Value Chain Analysis
- 9.1.1 Hydroxyzine Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Hydroxyzine Production Mode & Process
- 9.2 Hydroxyzine Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Hydroxyzine Distributors
- 9.2.3 Hydroxyzine Customers
- 10 Concluding Insights
- 11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.